People search this because some users report drinking less or feeling less interested in alcohol. The science is interesting, but still emerging.
GLP-1 receptor agonists are being studied for alcohol use disorder and reward-related behavior. A 2025 randomized clinical trial evaluated once-weekly semaglutide in adults with alcohol use disorder. That is meaningful, but it does not settle who benefits, how durable effects are, or whether observations apply to everyone taking semaglutide for diabetes or weight management.
| Track this | Why |
|---|---|
| Craving 0-10 | Turns a vague “drinking less” feeling into a comparable signal. |
| Drinks and timing | Helps connect alcohol to nausea, reflux, sleep, appetite, and next-day recovery. |
| Dose date and dose-change week | Many symptoms and appetite changes cluster around changes in dose or routine. |
| Sleep, mood, stress | These can drive cravings independently of medication. |